Skip to Main Content

### What I built and investigated Regulatory-variant prediction models are commonly evaluated against massively parallel reporter assays, or MPRAs, as though the assay were direct ground truth. I built an estimand-aware benchmark audit that first asks a more fundamental question: do the model and experiment estimate the same biological quantity? I applied this framework to 3,976 psychiatric-risk regulatory variants studied in the developing human cortex. I compared three sequence-to-function models—AlphaGenome, Borzoi, and Enformer—with a genomic language model, Evo 2; a developing-cortex lentiMPRA; and a fine-mapped fetal-cortex eQTL atlas used as an external endogenous anchor. With Claude, I implemented custom Bayesian measurement-error and latent-variable models, coordinated model scoring, checked the analysis for reproducibility and overclaiming, and produced a calibrated per-variant concordance map. The latent agreement estimator was validated through simulation-based calibration. ### What I found The three activity-predicting models showed strong agreement with one another, with rank correlations of approximately 0.55–0.81, but essentially no agreement with the lentiMPRA, with correlation around −0.02. Accounting for the reporter’s reported measurement uncertainty did not restore agreement, indicating that this uncertainty alone is insufficient to explain the gap. Evo 2 did not join either group, showing that “sequence model” does not represent a single estimand. The three activity models also showed modest agreement with the fine-mapped eQTL effects, with correlations of approximately 0.24–0.28, while the reporter showed essentially none. Among the 25 variants with the strongest fine-mapping support, model and eQTL directions agreed for 20. ### Why it matters The conclusion is not that computational models beat experiments. It is that a precise experimental measurement may still be a misaligned benchmark when it targets a different biological quantity. Here, the lentiMPRA measures an isolated DNA element in an ectopically integrated construct, while the models predict endogenous functional signals from native-locus sequence. Their disagreement is therefore consistent with a consequential estimand mismatch, although native-locus editing is still required to distinguish this explanation from model error and shared bias. The result is not a model-versus-assay winner. It is a calibrated map showing where the measurements agree, where they diverge, and which native-locus experiments would be most informative next.

Team

dshshadi

Placement

Participant

More from Built with Claude: Life Sciences

What I built. Lazarus is an agent that takes a dead research repository that is open, cited, and no longer runnable, and turns it back into a callable…

DoctorDean project preview

Diffuse midline glioma is a paediatric brainstem cancer that is almost uniformly fatal: about ninety percent of children die within two years, and the first…

Faith Ogundimu project preview

Hippocampus AI is the memory and reasoning engine for scientific discovery. Every experiment generates valuable knowledge, but that knowledge becomes…

Disruptors project preview

I used Claude to train a protein language model that can generate an extremophilic version of any enzyme, maintaining its function, while allowing it to…

Jaymin project preview

Many primates are sexually dichromatic — males and females are different colors. I wanted to know how that trait is built genetically, and how it evolved…

www.loom.com/…

About Trialign is a patient-facing clinical trial matcher for oncology. A patient pastes a clinical note, uploads a record, or connects their EHR via SMART on…

Trialign project preview